8 life sciences projects from leading research units in Europe will be presented, at the stage before establishing a company.

Subject:

• therapy: cardiovascular diseases, leukemia, neurological diseases, breast cancer
• diagnosis: Alzheimer’s disease and cancer
• platform technologies
• Cleantech

The solution of the Nencki Institute and the International Institute of Molecular and Cell Biology concerns the diagnosis of Alzheimer’s disease from blood (including early detection), a company for product development will soon be established.

The EU-LIFE Tech Transfer Working Group organizes yearly an online pitching event aimed at identifying promising projects with the potential for maturing into spin-offs. It offers the scientists leading these projects the opportunity to talk confidentially to venture capitalists (VCs) and professionals with venture creation experience, in order to gain insight in the different aspects they should take along in their projects in order to establish a new venture (such as which key data are needed or where should the business case be adjusted).